Date of Defense

Spring 4-18-1997


Speech Pathology and Audiology

First Advisor

Nickola Nelson, Speech Pathology and Audiology

Second Advisor

Harold Bate, Speech Pathology and Audiology

Third Advisor

Teresa Crumpton, Speech Pathology and Audiology


The Food and Drug Administration approved the use of Nucleus 22 multi-channel cochlear implants for children 2 to 17 years of age in June of 1990. Since that date, research concerning speech perception skills and educational implications for children with cochlear implants has been continuous. Sill, more research is needed concerning how children in mainstream general education classrooms use their audition. The present study was designed to assess the use of auditory skills to follow classroom directions. The participants of this study were children who wore cochlear implants and were placed in a mainstream classroom environment using total communication strategies and in interpreter.

Access Setting

Honors Thesis-Campus Only